| DIRECT COMPETITOR COMPARISON | |
| DDSS | BVF | DEPO | WPI | Industry | | Market Cap: | 104.50M | 2.21B | 171.12M | 4.07B | 100.49M | | Employees: | 124 | N/A | 81 | 5,070 | 280 | | Qtrly Rev Growth (yoy): | -29.80% | 17.40% | 63.10% | 3.30% | 9.60% | | Revenue (ttm): | 21.16M | 760.87M | 53.21M | 2.65B | 71.35M | | Gross Margin (ttm): | -2.60% | 71.90% | 17.88% | 44.90% | 50.77% | | EBITDA (ttm): | -22.07M | 359.76M | -28.72M | 642.17M | 724.20K | | Oper Margins (ttm): | -113.44% | 30.18% | -55.94% | 17.41% | 8.30% | | Net Income (ttm): | -32.54M | 223.84M | -29.63M | 221.48M | N/A | | EPS (ttm): | -0.571 | 1.413 | -0.578 | 1.940 | N/A | | P/E (ttm): | N/A | 9.88 | N/A | 19.75 | 17.56 | | PEG (5 yr expected): | N/A | 1.33 | N/A | 1.21 | 0.96 | | P/S (ttm): | 4.86 | 2.83 | 3.23 | 1.51 | 1.20 |
|
| BVF = Biovail Corporation | | DEPO = DepoMed Inc. | | WPI = Watson Pharmaceuticals Inc. | | Industry = Drug Related Products | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.49 | 0.73% | 57.18B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.37 | 0.42% | 13.99B | 16.19 | | Genzyme Corp. | GENZ | 49.68 | 0.93% | 13.18B | 28.32 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.36 | 0.78% | 41.72B | 17.93 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.60 | 1.14% | 9.02B | 1032.65 | | Teva Pharmaceutical Industries Limited | TEVA | 53.1354 | 0.62% | 46.81B | 48.61 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.32 | 1.78% | 4.07B | 19.75 | | King Pharmaceuticals Inc. | KG | 11.96 | 2.05% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.33 | 1.16% | 5.60B | 112.45 | | Pfizer Inc. | PFE | 18.38 | 0.77% | 148.32B | 15.27 | | Johnson & Johnson | JNJ | 64.8873 | 0.79% | 179.03B | 14.17 | | GlaxoSmithKline plc | GSK | 42.06 | 1.13% | 106.62B | 13.39 | | Sanofi-Aventis | SNY | 38.89 | 0.36% | 101.55B | N/A | | Novartis AG | NVS | 54.14 | -0.99% | 122.96B | 16.21 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.02 | 0.42% | N/A | N/A | | AstraZeneca plc | AZN | 45.299999 | -0.11% | 65.68B | 9.10 | | Abbott Laboratories | ABT | 54.08 | 0.88% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.69 | 2.31% | 50.89B | 13.29 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | WPI | | Biotech Stocks: Drug stocks climb; Lilly falls on forecast
Thu 10:51am -
at MarketWatch | | • | WPI | | Coverage initiated on Watson Pharm by Sun Trust Rbsn Humphrey
Thu 1:19am -
Briefing.com | | • | WPI | | Watson Acquires Arrow
Wed 11:49am -
Zacks.com | | • | WPI | | Which Health Care Sectors Will Benefit Under Impending Legislation? The Answer According To Lazard Capital
Wed 9:14am -
Wall Street Transcript | | • | WPI | | New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Wed 8:50am -
PR Newswire | | • | DEPO | | Prospecting for Stocks: DepoMed
Tue, Dec 8 -
at Motley Fool | | • | WPI | | Ratiopharm gets higher offers, to winnow bidders
Fri, Dec 4 -
at Reuters | | • | BVF | | SPECIAL REPORT-The FBI agent inside the Galleon case
Fri, Dec 4 -
at Reuters | | • | BVF | | The FBI agent inside the Galleon case
Fri, Dec 4 -
Reuters | | • | DEPO | | DEPOMED INC Files SEC form 8-K, Other Events
Thu, Dec 3 -
EDGAR Online | | • | BVF | | Abbott Makes All the Right Moves
Tue, Dec 1 -
at Motley Fool | | • | BVF | | Glaxo takes 19 percent stake in Aspen
Tue, Dec 1 -
AP | | • | DEPO | | UPDATE - Depomed sues India's Lupin for patent infringement
Mon, Nov 30 -
at Reuters | | • | DEPO | | Depomed Files Patent Infringement Lawsuit Against Lupin Limited
Mon, Nov 30 -
Business Wire | | • | DEPO | | Depomed to Present at Piper Jaffray's 21st Annual Health Care Conference
Tue, Nov 24 -
Business Wire | | • | BVF | | Biovail to Participate at Upcoming Conferences
Tue, Nov 10 -
Business Wire | | | All Headlines for these symbols... |
|
|
|
0.61% Nasdaq 
Competitors
